Indication

Lymph node positive colorectal carcinoma

Lymph node positive colorectal carcinoma refers to epithelial malignancy originating in the colon or rectum that has metastasized to regional lymph nodes, pathologically categorizing it as stage III disease in the absence of distant metastases. Read more about Lymph node positive colorectal carcinoma

59 drugs 51 manufacturers

Advertisement

Drugs that treat it

Common Lymph node positive colorectal carcinoma therapies.

Showing 19–27 of 59 drugs

CAPECITABINE

MALIGNANT ESOPHAGEAL NEOPLASM·+7
ROXANE/WEST-WAR

OXALIPLATIN

PLATINUM COMPOUNDS·METASTATIC COLORECTAL CANCER·+1
APP/FRESENIUS K

OXALIPLATIN

PLATINUM COMPOUNDS·METASTATIC COLORECTAL CANCER·+1
APP/FRESENIUS K

CAPECITABINE

MALIGNANT ESOPHAGEAL NEOPLASM·+7
Amneal Pharmaceuticals

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
RISING PHARM

OXALIPLATIN

PLATINUM COMPOUNDS·METASTATIC COLORECTAL CANCER·+1
APOTEX CORP

OXALIPLATIN

PLATINUM COMPOUNDS·METASTATIC COLORECTAL CANCER·+1
Hospira

OXALIPLATIN

METASTATIC COLORECTAL CANCER·+1
BRECKENRIDGE

OXALIPLATIN

PLATINUM COMPOUNDS·METASTATIC COLORECTAL CANCER·+1
Hospira
Filter & compare in the drug finder →Opens the drug finder with Lymph node positive colorectal carcinoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Lymph node positive colorectal carcinoma.

Lymph node positive colorectal carcinoma refers to epithelial malignancy originating in the colon or rectum that has metastasized to regional lymph nodes, pathologically categorizing it as stage III disease in the absence of distant metastases.

This condition affects the gastrointestinal and lymphatic systems, occurring primarily in adult populations.

Pathophysiologically, malignant cells breach the intestinal basement membrane, penetrate through layers of the bowel wall, and enter the regional lymphatic drainage, resulting in metastatic tumor deposits within paracolic, mesocolic, or mesorectal nodes.

It is clinically defined by histopathologic evidence of one or more involved regional lymph nodes (N1 or N2 classification), representing an elevated risk of systemic recurrence that typically guides the use of adjuvant therapy.

Personalize your experience

Follow Lymph node positive colorectal carcinoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it